JP2024072283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024072283A5 JP2024072283A5 JP2023194117A JP2023194117A JP2024072283A5 JP 2024072283 A5 JP2024072283 A5 JP 2024072283A5 JP 2023194117 A JP2023194117 A JP 2023194117A JP 2023194117 A JP2023194117 A JP 2023194117A JP 2024072283 A5 JP2024072283 A5 JP 2024072283A5
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- compound
- acceptable salt
- ceutically acceptable
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 29
- 150000003839 salts Chemical class 0.000 claims 25
- 239000000203 mixture Substances 0.000 claims 19
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 1
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024186560A JP2025032072A (ja) | 2022-11-15 | 2024-10-23 | Ａｈｒアゴニスト |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263425442P | 2022-11-15 | 2022-11-15 | |
| US63/425,442 | 2022-11-15 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024186560A Division JP2025032072A (ja) | 2022-11-15 | 2024-10-23 | Ａｈｒアゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024072283A JP2024072283A (ja) | 2024-05-27 |
| JP2024072283A5 true JP2024072283A5 (https=) | 2024-10-21 |
| JP7577819B2 JP7577819B2 (ja) | 2024-11-05 |
Family
ID=89121650
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023194117A Active JP7577819B2 (ja) | 2022-11-15 | 2023-11-15 | Ａｈｒアゴニスト |
| JP2024186560A Pending JP2025032072A (ja) | 2022-11-15 | 2024-10-23 | Ａｈｒアゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024186560A Pending JP2025032072A (ja) | 2022-11-15 | 2024-10-23 | Ａｈｒアゴニスト |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240199608A1 (https=) |
| EP (1) | EP4619401A1 (https=) |
| JP (2) | JP7577819B2 (https=) |
| KR (1) | KR20250083557A (https=) |
| CN (1) | CN120225518A (https=) |
| AR (1) | AR131070A1 (https=) |
| AU (1) | AU2023382389A1 (https=) |
| CL (1) | CL2025001421A1 (https=) |
| CO (1) | CO2025005456A2 (https=) |
| CR (1) | CR20250175A (https=) |
| DO (1) | DOP2025000111A (https=) |
| IL (1) | IL320832A (https=) |
| JO (1) | JOP20250109A1 (https=) |
| MX (1) | MX2025005566A (https=) |
| PE (1) | PE20251588A1 (https=) |
| TW (2) | TW202523664A (https=) |
| WO (1) | WO2024107555A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025240124A1 (en) * | 2024-05-14 | 2025-11-20 | Eli Lilly And Company | Processes for preparing enantiomeric compounds and related molecules |
| CN120904199B (zh) * | 2025-09-30 | 2026-03-06 | 上海泽德曼医药科技有限公司 | 具有稠环结构的化合物及其在医药上的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2510528A1 (de) * | 1975-03-11 | 1976-09-23 | Hoechst Ag | Benzimidazo-/1,2-a/-chinoline und verfahren zu ihrer herstellung |
| NL7709746A (nl) * | 1976-09-09 | 1978-03-13 | Hoechst Ag | Werkwijze ter bereiding van benzimidazo-(1,2-a)-chi- nolinen. |
| IE52670B1 (en) | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
| CN1149214C (zh) | 1998-12-04 | 2004-05-12 | 东丽株式会社 | 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂 |
| ATE463482T1 (de) | 2002-07-25 | 2010-04-15 | Janssen Pharmaceutica Nv | Chinolinderivate und deren verwendung als mycobakterielle inhibitoren |
| AU2004220176A1 (en) * | 2003-03-14 | 2004-09-23 | Astrazeneca Ab | Novel fused triazolones and the uses thereof |
| JP2007506788A (ja) * | 2003-09-26 | 2007-03-22 | ライジェル ファーマシューティカルズ， インコーポレイテッド | Ｈｃｖ感染阻害剤とその使用法 |
| PL1753427T3 (pl) * | 2004-05-28 | 2008-09-30 | Janssen Pharmaceutica Nv | Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne |
| WO2007074491A1 (en) | 2005-12-28 | 2007-07-05 | Universita Degli Studi Di Siena | HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS |
| WO2008014307A2 (en) | 2006-07-26 | 2008-01-31 | Novartis Ag | Inhibitors of undecaprenyl pyrophosphate synthase |
| GB0919432D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Use |
| WO2018171602A1 (zh) | 2017-03-21 | 2018-09-27 | 正大天晴药业集团股份有限公司 | 用于ido和tdo双重抑制剂的脲类化合物 |
| US12312337B2 (en) * | 2019-05-10 | 2025-05-27 | Antidote Ip Holdings, Llc | Compounds and methods for treating cancer |
| AR126963A1 (es) * | 2021-09-13 | 2023-12-06 | Lilly Co Eli | Agonistas de ahr |
-
2023
- 2023-11-03 PE PE2025000850A patent/PE20251588A1/es unknown
- 2023-11-03 IL IL320832A patent/IL320832A/en unknown
- 2023-11-03 CN CN202380078645.4A patent/CN120225518A/zh active Pending
- 2023-11-03 US US18/501,175 patent/US20240199608A1/en active Pending
- 2023-11-03 EP EP23818599.5A patent/EP4619401A1/en active Pending
- 2023-11-03 AU AU2023382389A patent/AU2023382389A1/en active Pending
- 2023-11-03 CR CR20250175A patent/CR20250175A/es unknown
- 2023-11-03 WO PCT/US2023/078633 patent/WO2024107555A1/en not_active Ceased
- 2023-11-03 KR KR1020257015398A patent/KR20250083557A/ko active Pending
- 2023-11-15 JP JP2023194117A patent/JP7577819B2/ja active Active
- 2023-11-15 AR ARP230103075A patent/AR131070A1/es unknown
- 2023-11-15 TW TW114105013A patent/TW202523664A/zh unknown
- 2023-11-15 TW TW112144125A patent/TWI870104B/zh active
-
2024
- 2024-10-23 JP JP2024186560A patent/JP2025032072A/ja active Pending
-
2025
- 2025-04-29 CO CONC2025/0005456A patent/CO2025005456A2/es unknown
- 2025-05-13 CL CL2025001421A patent/CL2025001421A1/es unknown
- 2025-05-13 JO JOJO/P/2025/0109A patent/JOP20250109A1/ar unknown
- 2025-05-13 MX MX2025005566A patent/MX2025005566A/es unknown
- 2025-05-14 DO DO2025000111A patent/DOP2025000111A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024072283A5 (https=) | ||
| RU2014110623A (ru) | Пирролопиразиновые ингибиторы киназы | |
| RU2013126041A (ru) | Пиразолопиридины и пиразолопиридины и их применение в качестве ингибиторов tyk2 | |
| EP1915994B1 (en) | Cyclic amine derivatives in combination with ppar regulators | |
| CA2574600A1 (en) | Pyridine derivatives | |
| JP2021515004A5 (https=) | ||
| JP2017504640A5 (https=) | ||
| JP2015535851A5 (https=) | ||
| IL320832A (en) | AHR agonists | |
| RU97102043A (ru) | Замещенные бензамидины, их получение и применение в качестве лекарственных средств | |
| JP2020111571A5 (https=) | ||
| AU600939B2 (en) | 2-substituted-amino-4,5-dihydro-oxa,thia and imidazole derivatives | |
| JPWO2021055621A5 (https=) | ||
| JPWO2022241171A5 (https=) | ||
| JPWO2021071802A5 (https=) | ||
| JPWO2022212489A5 (https=) | ||
| JPWO2019213470A5 (https=) | ||
| JP2016539983A5 (https=) | ||
| JPWO2021071806A5 (https=) | ||
| JPWO2021092246A5 (https=) | ||
| JPWO2021071821A5 (https=) | ||
| KR880006239A (ko) | 기라제 억제제, 그의 제조방법 및 용도 | |
| JP2017532299A5 (https=) | ||
| JPWO2022232025A5 (https=) | ||
| JPWO2021231726A5 (https=) |